<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39436355</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2373-8227</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>ACS infectious diseases</Title><ISOAbbreviation>ACS Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Role of RNA G-Quadruplexes in the Japanese Encephalitis Virus Genome and Their Recognition as Prospective Antiviral Targets.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acsinfecdis.4c00507</ELocationID><Abstract><AbstractText>G-quadruplexes (GQs) have been primarily studied in the context of cancer and neurodegenerative pathologies. However, recent research has shifted focus to their existence and functional roles in viral genomes, revealing GQ-regulated key pathways in various human pathogenic viruses. While GQ structures have been reported in the genomes of emerging and re-emerging viruses, RNA viruses have been understudied compared to DNA viruses, including notable examples such as human immunodeficiency virus-1, hepatitis C virus, Ebola virus, Nipah virus, Zika virus, and SARS-CoV-2. The flavivirus family, comprising the Japanese encephalitis virus (JEV), poses a significant global threat due to recurring outbreaks yet lacks approved antivirals. In this study, we identified and characterized eight putative G-quadruplex-forming motifs within essential genes involved in genome replication, assembly, and internalization in the host cell, conserved across different JEV isolates. The formation and stability of these motifs were validated through a multitude of biophysical and cell-based assays. The interaction and binding affinity of these motifs with the known GQ-binding ligand BRACO-19 were supported by biophysical assays, confirming the capability of these motifs to form GQ structures. Notably, BRACO-19 also exerted antiviral properties through reduction of viral replication and infectious virus titers as well as inhibition of viral protein expression, as evaluated by the cell-based assays. This comprehensive molecular characterization of G-quadruplex structures within the JEV genome highlights their potential as promising antiviral targets for intervention strategies against JEV infection through GQ-specific ligands.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Aakriti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol 453552, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majee</LastName><ForeName>Prativa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol 453552, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Laxmi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Virology Research Group, Regional Centre for Biotechnology, Faridabad 121001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prajapat</LastName><ForeName>Surendra Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Virology Research Group, Regional Centre for Biotechnology, Faridabad 121001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Tarun Kumar</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0002-0065-6099</Identifier><AffiliationInfo><Affiliation>Department of Medical Biotechnology, Gujarat Biotechnology University, Gandhinagar 382355, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalia</LastName><ForeName>Manjula</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Virology Research Group, Regional Centre for Biotechnology, Faridabad 121001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Amit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5913-4308</Identifier><AffiliationInfo><Affiliation>Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol 453552, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Infect Dis</MedlineTA><NlmUniqueID>101654580</NlmUniqueID><ISSNLinking>2373-8227</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BRACO-19</Keyword><Keyword MajorTopicYN="N">G-quadruplexes (GQs)</Keyword><Keyword MajorTopicYN="N">Japanese encephalitis virus (JEV)</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">flavivirus</Keyword><Keyword MajorTopicYN="N">therapeutic targets</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>10</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39436355</ArticleId><ArticleId IdType="doi">10.1021/acsinfecdis.4c00507</ArticleId></ArticleIdList></PubmedData></PubmedArticle>